Immuneering’s CPO Buys More Shares Amid Volatile Prices: Insider Confidence Persists in the Face of Downturns
Immuneering insider buying rises amid volatility—Leah Neufeld’s latest purchase shows leadership confidence, a “buy‑the‑dip” strategy for investors.
3 minutes to read
